HHOLF yields 4000.00% · JNJ yields 2.13%● Live data
📍 HHOLF pulled ahead of the other in Year 1
Combined, HHOLF + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of HHOLF + JNJ for your $10,000?
Herald Holdings Limited, together with its subsidiaries, engages in the manufacture, sale, and distribution of toys, computer products, housewares, clocks, watches, and electronic and gift products. It offers a range of toys, including action figures, electronic radio-controlled toy cars and boats, electronic games, and pre-school toys; battery-operated and electronic toys, games, radio-controlled vehicles, transformers, and model kits and gift items. The company provides computer products, including magnetic tape head, thin-film tape heads, and motor actuator assemblies, as well as smart connected devices for Internet of Things comprising smart watches, thermostats, sensory array gateways, and remote environmental sensors; and manufactures and sells watches under the Braun, Vivienne Westwood, and Lambretta brands. In addition, it is involved in the property investment and leasing activities; provision of marketing services; and debt and equity securities, and managed funds investment activities, as well as sells and distributes clocks, watches, and electronic products. Herald Holdings Limited operates in Hong Kong, North America, the United Kingdom, rest of Europe, Asia, Mainland China, and internationally. The company was incorporated in 1992 and is headquartered in Hong Kong, Hong Kong.
Full HHOLF Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.